Thunbnail image
News   >  Nephrology   >  

Semaglutide: A Lifeline for Kidney Health in Obesity and Heart Disease

Published: 5/27/2024
      
Semaglutide
Kidney health
Obesity
Cardiovascular disease
GLP-1 receptor agonist
Weight loss
Chronic kidney disease
Glomerular filtration rate
Albumin-to-creatinine ratio
Macroalbuminuria

Key Takeaways

  • Semaglutide may reduce kidney-related risks in people with obesity and heart disease.
  • Participants experienced significant kidney benefits with weekly semaglutide injections.
  • More research is needed to fully understand semaglutide's impact on kidney health.

Did You Know?

Did you know? Semaglutide could potentially help prevent kidney disease in people with excess weight, beyond its known benefits for diabetes and obesity.

Introduction to Semaglutide

Semaglutide is a medication that has gained popularity for its effectiveness in treating diabetes and obesity. It's sold under the brand names Ozempic and Wegovy. Recent studies have examined its potential benefits beyond blood sugar control and weight loss. A new area of interest is the medication's impact on kidney health.

The Role of Kidneys and Risks for Kidney Disease

Kidneys are vital organs responsible for filtering waste products and excess substances from the blood. People who are overweight or have cardiovascular disease (CVD) are at a higher risk of developing kidney issues. This is due to the increased strain on kidneys from high blood pressure, poor glucose metabolism, and inflammation, which can lead to chronic kidney disease (CKD).

Study Findings on Semaglutide and Kidney Function

A research study presented at the 61st ERA Congress explored how semaglutide can help protect kidney function. The study reviewed health data from a trial involving 17,604 participants who were overweight or had obesity and heart disease. Over 3.5 years, the researchers tracked kidney-related events among those who received weekly injections of semaglutide.

Results: Fewer Kidney-Related Events

The findings were promising—22% fewer participants in the semaglutide group experienced kidney-related events compared to those who took a placebo. These events included significant declines in kidney functioning, the onset of chronic kidney replacement therapy, persistent macroalbuminuria, or death. This suggests that semaglutide may offer protective benefits for the kidneys.

How Semaglutide Benefits the Kidneys

Semaglutide appears to aid the kidneys by improving their ability to filter blood. Participants who took the medication had lesser declines in their glomerular filtration rates (GFR), indicating better kidney health. Additionally, they had significant decreases in urinary albumin-to-creatinine ratios and macroalbuminuria—problems where the body excretes excess protein through urine daily.

Benefits Observed Across Different Health States

Interestingly, these benefits were observed even in participants who had normal kidney function at the start of the study. This broad protective effect underscores the potential of semaglutide as a preventative measure against kidney issues.

Mechanisms of Action: Weight Loss and Beyond

One of the mechanisms by which semaglutide may help the kidneys is through weight loss. In the study, participants lost about 9% of their body weight over two years. Reducing body weight decreases the filtering load on the kidneys, potentially prolonging kidney function and overall lifespan.

Anti-Inflammatory and Glucose Metabolism Effects

Semaglutide may also improve glucose metabolism and lower inflammation in the body, which are beneficial for kidney health. Better glucose control can reduce the strain on kidneys, while lower inflammation may prevent kidney damage over time.

Future Research and Potential Side Effects

While the findings are encouraging, more research is needed to fully understand semaglutide's effects on kidney function. It's important to consider possible side effects before using semaglutide primarily for kidney health. These insights could guide future obesity treatments and inform ongoing research on GLP-1 receptor agonists.

The Broader Implications for Health

People with excess weight often face higher risks of developing diabetes and hypertension, both of which can exacerbate kidney problems. The study results suggest that semaglutide might help minimize these risk factors, therefore preventing kidney disease. Adding kidney protection to the list of benefits can make semaglutide an attractive option for physicians managing patients with multiple health concerns.

References

  1. Semaglutide for Weight Loss in Patients with Overweight or Obesity
    https://www.nejm.org/doi/full/10.1056/nejmoa2032183
  2. Effects of semaglutide on kidney function
    https://clinicaltrials.gov/ct2/show/NCT03819153
  3. ERA Congress 2023: Insights into new kidney research
    https://www.era-online.org/congress/2023